Matches in DBpedia 2016-04 for { ?s ?p "Piromelatine (Neu-P11) is a multimodal sleep drug under development by Neurim Pharmaceuticals. It is an agonist at melatonin MT1/MT2 and serotonin 5-HT1A/5-HT1D receptors. Nuerim is doing a phase II randomized, placebo controlled trial of cognitive and sleep effects in Alzheimer's disease.Results of a phase II trial on insomnia in 120 adults were announced in 2013, finding piromelatine 20/50 mg improved sleep over 4 weeks vs placebo."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Piromelatine comment "Piromelatine (Neu-P11) is a multimodal sleep drug under development by Neurim Pharmaceuticals. It is an agonist at melatonin MT1/MT2 and serotonin 5-HT1A/5-HT1D receptors. Nuerim is doing a phase II randomized, placebo controlled trial of cognitive and sleep effects in Alzheimer's disease.Results of a phase II trial on insomnia in 120 adults were announced in 2013, finding piromelatine 20/50 mg improved sleep over 4 weeks vs placebo.".
- Q18388725 comment "Piromelatine (Neu-P11) is a multimodal sleep drug under development by Neurim Pharmaceuticals. It is an agonist at melatonin MT1/MT2 and serotonin 5-HT1A/5-HT1D receptors. Nuerim is doing a phase II randomized, placebo controlled trial of cognitive and sleep effects in Alzheimer's disease.Results of a phase II trial on insomnia in 120 adults were announced in 2013, finding piromelatine 20/50 mg improved sleep over 4 weeks vs placebo.".